Stockscreener 앱 받기
5.84
3.00%
0.17
시간 외 거래:
5.79
-0.05
-0.86%
Ardelyx Inc 주식(ARDX)의 최신 뉴스
ARDX (NASDAQ) insider sales: 125,000 shares notice; Raab 10b5-1 trades listed - Stock Titan
ARDX edges up after hours on IBSRELA momentum and profitability 'right around the corner' - MSN
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx (ARDX) Stock Valuation Check After Recent Share Price Volatility - Yahoo Finance
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
Ardelyx eyes $500M+ revenue as IBSRELA growth puts profitability within reach - MSN
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Hyperphosphatemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 – DelveInsight | Ardelyx, Sanofi, Takeda Pharma, Unicycive Therapeutics, Taisho Pharma, Alebund Pharma - Barchart
ARDX Q1 2026 Earnings: Earnings Miss But Stock Gains as Investors Focus on Pipeline ProgressHigh Estimate Range - newsline.com
ARDX Q1 2026 Earnings: EPS Misses Estimates Slightly, Stock Gains Amid Mixed SignalsEarnings Revision Report - newsline.com
· SEC Filing - MLQ.ai
Assessing Ardelyx (ARDX) Valuation After Recent Share Price Pullback And Growth Expectations - simplywall.st
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - TMX Newsfile
Ardelyx Advances Long-Term Tenapanor Trial in Chronic Constipation: What Investors Should Watch - TipRanks
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach - TradingView
ARDX: IBSRELA and XPHOZAH are set for robust growth, targeting $1B and $750M revenues by 2029 - TradingView
IBSRELA-Fueled Q1 Surge and AI Spotlight Could Be A Game Changer For Ardelyx (ARDX) - simplywall.st
ARDX Technical Analysis & Stock Price Forecast - Intellectia AI
Should You Buy Ardelyx (ARDX)? - Insider Monkey
What Triggered Ardelyx's Post-Earnings Plunge - Kavout
Ardelyx Inc. (ARDX) Q1 2026 Earnings: EPS Misses Estimates, but Stock Edges Higher Amid Strategic MomentumProduct Revenue Analysis - newsline.com
This Insider Has Just Sold Shares In Ardelyx - simplywall.st
Ardelyx Inc Live Share Prices and Trades. ARDX.US Live Streaming Share Prices. - London South East
Ardelyx (ARDX) price target increased by 12.82% to 13.46 - MSN
ARDX Q1 2026 Earnings: EPS Misses Estimates Amid Quiet Revenue DisclosureEarnings Surprise Score - newsline.com
Ardelyx chief patient officer sells $43,803 in shares By Investing.com - Investing.com Canada
Ardelyx chief patient officer sells $43,803 in shares - Investing.com
Tax-related Ardelyx (ARDX) insider sale covers RSU withholding needs - Stock Titan
Ardelyx (ARDX) CFO executes 1,455-share tax sell-to-cover after RSU vest - Stock Titan
Ardelyx (ARDX) officer’s RSU vesting triggers 2,306-share tax sell - Stock Titan
Ardelyx (ARDX) HR chief sells 1,846 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) Chief Commercial Officer sells 7,998 shares to cover RSU taxes - Stock Titan
2.60%
0.94%
자본화:
|
볼륨(24시간):